{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T21:18:15Z","timestamp":1761167895606,"version":"build-2065373602"},"reference-count":146,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272929","82473459"],"award-info":[{"award-number":["82272929","82473459"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012247","name":"Program of Shanghai Academic\/Technology Research Leader","doi-asserted-by":"crossref","award":["23XD1400600"],"award-info":[{"award-number":["23XD1400600"]}],"id":[{"id":"10.13039\/501100012247","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanghai Science and Technology Commission Innovative Pharmaceutical Products Application Demonstration Project","award":["24SF1900300"],"award-info":[{"award-number":["24SF1900300"]}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"crossref","award":["20244Y0023"],"award-info":[{"award-number":["20244Y0023"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanghai Magnolia Talent Plan Pujiang Programme","award":["24PJD012"],"award-info":[{"award-number":["24PJD012"]}]},{"name":"Shanghai Anticancer Association EYAS PROJECT","award":["SACA-CY24B09"],"award-info":[{"award-number":["SACA-CY24B09"]}]},{"DOI":"10.13039\/100018904","name":"Beijing Xisike Clinical Oncology Research Foundation","doi-asserted-by":"crossref","award":["Y-2022METAZQN-0003"],"award-info":[{"award-number":["Y-2022METAZQN-0003"]}],"id":[{"id":"10.13039\/100018904","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Clinical Research of Zhongshan Hospital","award":["ZSLCYJ202329"],"award-info":[{"award-number":["ZSLCYJ202329"]}]},{"name":"Liu Liang Expert Workstation of Yunnan Province","award":["202305AF150148"],"award-info":[{"award-number":["202305AF150148"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"DOI":"10.1007\/s10555-025-10295-x","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:21:33Z","timestamp":1761042093000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical subtypes of stage IV pancreatic ductal adenocarcinoma: a new perspective of clinical practices"],"prefix":"10.1007","volume":"44","author":[{"given":"Yi-Fei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Quan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"issue":"3","key":"10295_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 74(3), 229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"1","key":"10295_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel, R. L., Giaquinto, A. N., & Jemal, A. (2024). Cancer statistics, 2024. CA: A Cancer Journal for Clinicians, 74(1), 12\u201349. https:\/\/doi.org\/10.3322\/caac.21820","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"3","key":"10295_CR3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nrclinonc.2009.236","volume":"7","author":"A Stathis","year":"2010","unstructured":"Stathis, A., & Moore, M. J. (2010). Advanced pancreatic carcinoma: Current treatment and future challenges. Nature Reviews Clinical Oncology, 7(3), 163\u2013172. https:\/\/doi.org\/10.1038\/nrclinonc.2009.236","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"11","key":"10295_CR4","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib, L., Smith, B. D., Aizenberg, R., Rosenzweig, A. B., Fleshman, J. M., & Matrisian, L. M. (2014). Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the United States [Review]. Cancer Research, 74(11), 2913\u20132921. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-0155","journal-title":"Cancer Research"},{"issue":"5","key":"10295_CR5","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1001\/jama.2019.10232","volume":"322","author":"USPST Force","year":"2019","unstructured":"Force, U. S. P. S. T., Owens, D. K., Davidson, K. W., Krist, A. H., Barry, M. J., Cabana, M., Caughey, A. B., Curry, S. J., Doubeni, C. A., Epling, J. W., Jr., Kubik, M., Landefeld, C. S., Mangione, C. M., Pbert, L., Silverstein, M., Simon, M. A., Tseng, C. W., & Wong, J. B. (2019). Screening for pancreatic cancer: US preventive services task force reaffirmation recommendation statement. JAMA, 322(5), 438\u2013444. https:\/\/doi.org\/10.1001\/jama.2019.10232","journal-title":"JAMA"},{"issue":"1","key":"10295_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.22","volume":"2","author":"J Kleeff","year":"2016","unstructured":"Kleeff, J., Korc, M., Apte, M., La Vecchia, C., Johnson, C. D., Biankin, A. V., Neale, R. E., Tempero, M., Tuveson, D. A., Hruban, R. H., & Neoptolemos, J. P. (2016). Pancreatic cancer. Nature Reviews Disease Primers, 2(1), Article 16022. https:\/\/doi.org\/10.1038\/nrdp.2016.22","journal-title":"Nature Reviews Disease Primers"},{"issue":"4","key":"10295_CR7","doi-asserted-by":"publisher","first-page":"439","DOI":"10.6004\/jnccn.2021.0017","volume":"19","author":"MA Tempero","year":"2021","unstructured":"Tempero, M. A., Malafa, M. P., Al-Hawary, M., Behrman, S. W., Benson, A. B., Cardin, D. B., Chiorean, E. G., Chung, V., Czito, B., Del Chiaro, M., Dillhoff, M., Donahue, T. R., Dotan, E., Ferrone, C. R., Fountzilas, C., Hardacre, J., Hawkins, W. G., Klute, K., Ko, A. H., \u2026 George, G. V. (2021). Pancreatic adenocarcinoma, version 2.2021, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network, 19(4), 439\u2013457. https:\/\/doi.org\/10.6004\/jnccn.2021.0017","journal-title":"Journal of the National Comprehensive Cancer Network"},{"issue":"3 Pt 2","key":"10295_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2019.02.025","volume":"48","author":"C Springfeld","year":"2019","unstructured":"Springfeld, C., Jager, D., Buchler, M. W., Strobel, O., Hackert, T., Palmer, D. H., & Neoptolemos, J. P. (2019). Chemotherapy for pancreatic cancer. La Presse M\u00e9dicale, 48(3 Pt 2), Article e159. https:\/\/doi.org\/10.1016\/j.lpm.2019.02.025","journal-title":"La Presse M\u00e9dicale"},{"issue":"2","key":"10295_CR9","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1053\/j.gastro.2022.03.056","volume":"163","author":"LD Wood","year":"2022","unstructured":"Wood, L. D., Canto, M. I., Jaffee, E. M., & Simeone, D. M. (2022). Pancreatic cancer: Pathogenesis, screening, diagnosis, and treatment. Gastroenterology, 163(2), 386-402e381. https:\/\/doi.org\/10.1053\/j.gastro.2022.03.056","journal-title":"Gastroenterology"},{"issue":"8","key":"10295_CR10","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook, C. J., Lyssiotis, C. A., Pasca di Magliano, M., & Maitra, A. (2023). Pancreatic cancer: Advances and challenges. Cell, 186(8), 1729\u20131754. https:\/\/doi.org\/10.1016\/j.cell.2023.02.014","journal-title":"Cell"},{"key":"10295_CR11","doi-asserted-by":"publisher","unstructured":"Graus, M., van Diepen, A. E., Josemanders, K., Besselink, M. G., Bouwense, S. A. W., Daamen, L. A., de Hingh, I., de Jong, E. J. M., van Laarhoven, H. W. M., de Meijer, V. E., Quintus Molenaar, I., Stommel, M. W. J., Valkenburg-van Iersel, L. B. J., Wilmink, J. W., van der Geest, L. G. M., de Vos-Geelen, J., & Dutch Pancreatic Cancer, G. (2025). Patterns of disease dissemination and survival in patients with synchronous and metachronous metastatic pancreatic adenocarcinoma: Nationwide population-based study. European Journal of Cancer, 220, 115385. https:\/\/doi.org\/10.1016\/j.ejca.2025.115385","DOI":"10.1016\/j.ejca.2025.115385"},{"key":"10295_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2024.06.004","author":"JM Levine","year":"2024","unstructured":"Levine, J. M., Rompen, I. F., Franco, J. C., Swett, B., Kryschi, M. C., Habib, J. R., Diskin, B., Hewitt, D. B., Sacks, G. D., Kaplan, B., Berman, R. S., Cohen, S. M., Wolfgang, C. L., & Javed, A. A. (2024). The impact of metastatic sites on survival rates and predictors of extended survival in patients with metastatic pancreatic cancer. Pancreatology. https:\/\/doi.org\/10.1016\/j.pan.2024.06.004","journal-title":"Pancreatology"},{"issue":"4","key":"10295_CR13","doi-asserted-by":"publisher","first-page":"e798","DOI":"10.1097\/SLA.0000000000005753","volume":"278","author":"SR Kaslow","year":"2023","unstructured":"Kaslow, S. R., Sacks, G. D., Berman, R. S., Lee, A. Y., & Correa-Gallego, C. (2023). Natural history of stage IV pancreatic cancer. Identifying survival benchmarks for curative-intent resection in patients with synchronous liver-only metastases. Annals Of Surgery, 278(4), e798\u2013e804. https:\/\/doi.org\/10.1097\/SLA.0000000000005753","journal-title":"Annals Of Surgery"},{"key":"10295_CR14","doi-asserted-by":"publisher","unstructured":"Nguyen, B., Fong, C., Luthra, A., Smith, S. A., DiNatale, R. G., Nandakumar, S., Walch, H., Chatila, W. K., Madupuri, R., Kundra, R., Bielski, C. M., Mastrogiacomo, B., Donoghue, M. T. A., Boire, A., Chandarlapaty, S., Ganesh, K., Harding, J. J., Iacobuzio-Donahue, C. A., Razavi, P.,\u2026Schultz, N. (2022). Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients. Cell, 185(3), 563\u2013575.e511. https:\/\/doi.org\/10.1016\/j.cell.2022.01.003","DOI":"10.1016\/j.cell.2022.01.003"},{"issue":"1","key":"10295_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100388","volume":"7","author":"SF Kruger","year":"2022","unstructured":"Kruger, S. F., Lohneis, A., Abendroth, A., Berger, A. W., Ettrich, T. J., Waidmann, O., Kapp, M., Steiner, B., Kumbrink, J., Reischer, A., Haas, M., Westphalen, C. B., Zhang, D., Miller-Phillips, L., Burger, P. J., Kobold, S., Werner, J., Subklewe, M., von Bergwelt-Baildon, M., & Boeck, S. (2022). Prognosis and tumor biology of pancreatic cancer patients with isolated lung metastases: Translational results from the German multicenter AIO-YMO-PAK-0515 study. Esmo Open, 7(1), Article 100388. https:\/\/doi.org\/10.1016\/j.esmoop.2022.100388","journal-title":"Esmo Open"},{"issue":"10","key":"10295_CR16","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.3748\/wjg.v23.i10.1872","volume":"23","author":"H Oweira","year":"2017","unstructured":"Oweira, H., Petrausch, U., Helbling, D., Schmidt, J., Mannhart, M., Mehrabi, A., Schob, O., Giryes, A., Decker, M., & Abdel-Rahman, O. (2017). Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A surveillance epidemiology and end results database analysis. World Journal of Gastroenterology, 23(10), 1872\u20131880. https:\/\/doi.org\/10.3748\/wjg.v23.i10.1872","journal-title":"World Journal of Gastroenterology"},{"issue":"34","key":"10295_CR17","doi-asserted-by":"publisher","first-page":"55368","DOI":"10.18632\/oncotarget.10552","volume":"7","author":"J de Ridder","year":"2016","unstructured":"de Ridder, J., de Wilt, J. H., Simmer, F., Overbeek, L., Lemmens, V., & Nagtegaal, I. (2016). Incidence and origin of histologically confirmed liver metastases: An explorative case-study of 23,154 patients. Oncotarget, 7(34), 55368\u201355376. https:\/\/doi.org\/10.18632\/oncotarget.10552","journal-title":"Oncotarget"},{"issue":"1","key":"10295_CR18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/MPA.0b013e3181e6e398","volume":"40","author":"H Ouyang","year":"2011","unstructured":"Ouyang, H., Wang, P., Meng, Z., Chen, Z., Yu, E., Jin, H., Chang, D. Z., Liao, Z., Cohen, L., & Liu, L. (2011). Multimodality treatment of pancreatic cancer with liver metastases using chemotherapy, radiation therapy, and\/or Chinese herbal medicine. Pancreas, 40(1), 120\u2013125. https:\/\/doi.org\/10.1097\/MPA.0b013e3181e6e398","journal-title":"Pancreas"},{"issue":"8","key":"10295_CR19","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1002\/jhbp.1303","volume":"30","author":"M Nagai","year":"2023","unstructured":"Nagai, M., Wright, M. J., Ding, D., Thompson, E. D., Javed, A. A., Weiss, M. J., Hruban, R. H., Yu, J., Burkhart, R. A., He, J., Cameron, J. L., Wolfgang, C. L., & Burns, W. R. (2023). Oncologic resection of pancreatic cancer with isolated liver metastasis: Favorable outcomes in select patients. Journal of Hepato-Biliary-Pancreatic Sciences, 30(8), 1025\u20131035. https:\/\/doi.org\/10.1002\/jhbp.1303","journal-title":"Journal of Hepato-Biliary-Pancreatic Sciences"},{"key":"10295_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/bjs\/znad338","author":"KF Boag","year":"2024","unstructured":"Boag, K. F., Britton, E., Knight, S. R., Coe, P. O., Chan, B., Blencowe, N. S., & Pathak, S. (2024). Definition and management of intra-abdominal metachronous oligometastatic pancreatic cancer: A systematic review. British Journal of Surgery. https:\/\/doi.org\/10.1093\/bjs\/znad338","journal-title":"British Journal of Surgery"},{"issue":"1","key":"10295_CR21","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1016\/s1470-2045(19)30718-1","volume":"21","author":"M Guckenberger","year":"2020","unstructured":"Guckenberger, M., Lievens, Y., Bouma, A. B., Collette, L., Dekker, A., deSouza, N. M., Dingemans, A. C., Fournier, B., Hurkmans, C., Lecouvet, F. E., Meattini, I., M\u00e9ndez Romero, A., Ricardi, U., Russell, N. S., Schanne, D. H., Scorsetti, M., Tombal, B., Verellen, D., Verfaillie, C., & Ost, P. (2020). Characterisation and classification of oligometastatic disease: A European society for radiotherapy and oncology and European organisation for research and treatment of cancer consensus recommendation. The Lancet Oncology, 21(1), e18\u2013e28. https:\/\/doi.org\/10.1016\/s1470-2045(19)30718-1","journal-title":"The Lancet Oncology"},{"key":"10295_CR22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.radonc.2020.04.003","volume":"148","author":"Y Lievens","year":"2020","unstructured":"Lievens, Y., Guckenberger, M., Gomez, D., Hoyer, M., Iyengar, P., Kindts, I., M\u00e9ndez Romero, A., Nevens, D., Palma, D., Park, C., Ricardi, U., Scorsetti, M., Yu, J., & Woodward, W. A. (2020). Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document. Radiotherapy and Oncology, 148, 157\u2013166. https:\/\/doi.org\/10.1016\/j.radonc.2020.04.003","journal-title":"Radiotherapy and Oncology"},{"issue":"10 Pt A","key":"10295_CR23","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/j.ejso.2020.06.013","volume":"46","author":"F Guerra","year":"2020","unstructured":"Guerra, F., Barucca, V., & Coletta, D. (2020). Metastases or primary recurrence to the lung is related to improved survival of pancreatic cancer as compared to other sites of dissemination. Results of a systematic review with meta-analysis. European Journal of Surgical Oncology, 46(10 Pt A), 1789\u20131794. https:\/\/doi.org\/10.1016\/j.ejso.2020.06.013","journal-title":"European Journal of Surgical Oncology"},{"issue":"8","key":"10295_CR24","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1002\/cam4.459","volume":"4","author":"RD Peixoto","year":"2015","unstructured":"Peixoto, R. D., Speers, C., McGahan, C. E., Renouf, D. J., Schaeffer, D. F., & Kennecke, H. F. (2015). Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancer. Cancer Medicine, 4(8), 1171\u20131177. https:\/\/doi.org\/10.1002\/cam4.459","journal-title":"Cancer Medicine"},{"issue":"5","key":"10295_CR25","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.pan.2021.03.006","volume":"21","author":"T Takeda","year":"2021","unstructured":"Takeda, T., Sasaki, T., Mie, T., Furukawa, T., Yamada, Y., Kasuga, A., Matsuyama, M., Ozaka, M., & Sasahira, N. (2021). Improved prognosis of pancreatic cancer patients with peritoneal metastasis. Pancreatology, 21(5), 903\u2013911. https:\/\/doi.org\/10.1016\/j.pan.2021.03.006","journal-title":"Pancreatology"},{"issue":"3","key":"10295_CR26","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.pan.2021.01.014","volume":"21","author":"C He","year":"2021","unstructured":"He, C., Huang, X., Zhang, Y., Lin, X., & Li, S. (2021). The impact of different metastatic patterns on survival in patients with pancreatic cancer. Pancreatology, 21(3), 556\u2013563. https:\/\/doi.org\/10.1016\/j.pan.2021.01.014","journal-title":"Pancreatology"},{"key":"10295_CR27","doi-asserted-by":"publisher","unstructured":"Huang, Q., Wu, X., Wang, Z., Chen, X., Wang, L., Lu, Y., Xiong, D., Liu, Q., Tian, Y., Lin, H., Guo, J., Wen, S., Dong, W., Yang, X., Yuan, Y., Yue, Z., Lei, S., Wu, Q., Ran, L.,\u2026Ye, L. (2022). The primordial differentiation of tumor-specific memory CD8+ T\u00a0cells as bona fide responders to PD-1\/PD-L1 blockade in draining lymph nodes. Cell, 185(22), 4049\u20134066.e4025. https:\/\/doi.org\/10.1016\/j.cell.2022.09.020","DOI":"10.1016\/j.cell.2022.09.020"},{"issue":"1","key":"10295_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13571-x","volume":"10","author":"S Milette","year":"2019","unstructured":"Milette, S., Hashimoto, M., Perrino, S., Qi, S., Chen, M., Ham, B., Wang, N., Istomine, R., Lowy, A. M., Piccirillo, C. A., & Brodt, P. (2019). Sexual dimorphism and the role of estrogen in the immune microenvironment of liver metastases. Nature Communications, 10(1), Article 5745. https:\/\/doi.org\/10.1038\/s41467-019-13571-x","journal-title":"Nature Communications"},{"issue":"2","key":"10295_CR29","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jhep.2010.10.005","volume":"54","author":"IN Crispe","year":"2011","unstructured":"Crispe, I. N. (2011). Liver antigen-presenting cells. Journal of Hepatology, 54(2), 357\u2013365. https:\/\/doi.org\/10.1016\/j.jhep.2010.10.005","journal-title":"Journal of Hepatology"},{"key":"10295_CR30","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev-immunol-051116-052415","volume":"36","author":"P Kubes","year":"2018","unstructured":"Kubes, P., & Jenne, C. (2018). Immune responses in the liver. Annual Review of Immunology, 36, 247\u2013277. https:\/\/doi.org\/10.1146\/annurev-immunol-051116-052415","journal-title":"Annual Review of Immunology"},{"issue":"4","key":"10295_CR31","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1053\/jhep.2003.50392","volume":"38","author":"O Vi\u00f1as","year":"2003","unstructured":"Vi\u00f1as, O., Bataller, R., Sancho-Bru, P., Gin\u00e8s, P., Berenguer, C., Enrich, C., Nicol\u00e1s, J. M., Ercilla, G., Gallart, T., Vives, J., Arroyo, V., & Rod\u00e9s, J. (2003). Human hepatic stellate cells show features of antigen-presenting cells and stimulate lymphocyte proliferation. Hepatology, 38(4), 919\u2013929. https:\/\/doi.org\/10.1053\/jhep.2003.50392","journal-title":"Hepatology"},{"issue":"1","key":"10295_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/TP.0b013e318294caae","volume":"96","author":"R Charles","year":"2013","unstructured":"Charles, R., Chou, H. S., Wang, L., Fung, J. J., Lu, L., & Qian, S. (2013). Human hepatic stellate cells inhibit T-cell response through B7\u2013H1 pathway. Transplantation, 96(1), 17\u201324. https:\/\/doi.org\/10.1097\/TP.0b013e318294caae","journal-title":"Transplantation"},{"issue":"2","key":"10295_CR33","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3892\/ijo.2012.1497","volume":"41","author":"W Zhao","year":"2012","unstructured":"Zhao, W., Su, W., Kuang, P., Zhang, L., Liu, J., Yin, Z., & Wang, X. (2012). The role of hepatic stellate cells in the regulation of T-cell function and the promotion of hepatocellular carcinoma. International Journal of Oncology, 41(2), 457\u2013464. https:\/\/doi.org\/10.3892\/ijo.2012.1497","journal-title":"International Journal of Oncology"},{"issue":"49","key":"10295_CR34","doi-asserted-by":"publisher","first-page":"14097","DOI":"10.1073\/pnas.1617903113","volume":"113","author":"Y Kimura","year":"2016","unstructured":"Kimura, Y., Inoue, A., Hangai, S., Saijo, S., Negishi, H., Nishio, J., Yamasaki, S., Iwakura, Y., Yanai, H., & Taniguchi, T. (2016). The innate immune receptor dectin-2 mediates the phagocytosis of cancer cells by Kupffer cells for the suppression of liver metastasis. Proceedings of the National Academy of Sciences of the United States of America, 113(49), 14097\u201314102. https:\/\/doi.org\/10.1073\/pnas.1617903113","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"10295_CR35","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/hep.510230542","volume":"23","author":"LG Bay\u00f3n","year":"1996","unstructured":"Bay\u00f3n, L. G., Izquierdo, M. A., Sirovich, I., van Rooijen, N., Beelen, R. H., & Meijer, S. (1996). Role of Kupffer cells in arresting circulating tumor cells and controlling metastatic growth in the liver. Hepatology, 23(5), 1224\u20131231. https:\/\/doi.org\/10.1002\/hep.510230542","journal-title":"Hepatology"},{"issue":"6","key":"10295_CR36","first-page":"1356","volume":"59","author":"AM Khatib","year":"1999","unstructured":"Khatib, A. M., Kontogiannea, M., Fallavollita, L., Jamison, B., Meterissian, S., & Brodt, P. (1999). Rapid induction of cytokine and E-selectin expression in the liver in response to metastatic tumor cells. Cancer Research, 59(6), 1356\u20131361.","journal-title":"Cancer Research"},{"issue":"7","key":"10295_CR37","doi-asserted-by":"publisher","first-page":"606","DOI":"10.4161\/cbt.24593","volume":"14","author":"SW Wen","year":"2013","unstructured":"Wen, S. W., Ager, E. I., & Christophi, C. (2013). Bimodal role of Kupffer cells during colorectal cancer liver metastasis. Cancer Biology & Therapy, 14(7), 606\u2013613. https:\/\/doi.org\/10.4161\/cbt.24593","journal-title":"Cancer Biology & Therapy"},{"issue":"1","key":"10295_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00261-6","volume":"7","author":"DI Tsilimigras","year":"2021","unstructured":"Tsilimigras, D. I., Brodt, P., Clavien, P. A., Muschel, R. J., D\u2019Angelica, M. I., Endo, I., Parks, R. W., Doyle, M., de Santibanes, E., & Pawlik, T. M. (2021). Liver metastases. Nature Reviews Disease Primers, 7(1), Article 27. https:\/\/doi.org\/10.1038\/s41572-021-00261-6","journal-title":"Nature Reviews Disease Primers"},{"issue":"3","key":"10295_CR39","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00018-017-2663-1","volume":"75","author":"J Mikula-Pietrasik","year":"2018","unstructured":"Mikula-Pietrasik, J., Uruski, P., Tykarski, A., & Ksiazek, K. (2018). The peritoneal \u201csoil\u201d for a cancerous \u201cseed\u201d: A comprehensive review of the pathogenesis of intraperitoneal cancer metastases. Cellular and Molecular Life Sciences, 75(3), 509\u2013525. https:\/\/doi.org\/10.1007\/s00018-017-2663-1","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"6","key":"10295_CR40","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s10585-005-2893-8","volume":"22","author":"NA Alkhamesi","year":"2005","unstructured":"Alkhamesi, N. A., Ziprin, P., Pfistermuller, K., Peck, D. H., & Darzi, A. W. (2005). ICAM-1 mediated peritoneal carcinomatosis, a target for therapeutic intervention. Clinical & Experimental Metastasis, 22(6), 449\u2013459. https:\/\/doi.org\/10.1007\/s10585-005-2893-8","journal-title":"Clinical & Experimental Metastasis"},{"issue":"2","key":"10295_CR41","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/ijc.25036","volume":"127","author":"K Ksiazek","year":"2010","unstructured":"Ksiazek, K., Miku\u0142a-Pietrasik, J., Catar, R., Dworacki, G., Winckiewicz, M., Frydrychowicz, M., Dragun, D., Staniszewski, R., J\u00f6rres, A., & Witowski, J. (2010). Oxidative stress-dependent increase in ICAM-1 expression promotes adhesion of colorectal and pancreatic cancers to the senescent peritoneal mesothelium. International Journal Of Cancer, 127(2), 293\u2013303. https:\/\/doi.org\/10.1002\/ijc.25036","journal-title":"International Journal Of Cancer"},{"issue":"1","key":"10295_CR42","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3892\/ijo.2014.2391","volume":"45","author":"S Akagawa","year":"2014","unstructured":"Akagawa, S., Ohuchida, K., Torata, N., Hattori, M., Eguchi, D., Fujiwara, K., Kozono, S., Cui, L., Ikenaga, N., Ohtsuka, T., Aishima, S., Mizumoto, K., Oda, Y., & Tanaka, M. (2014). Peritoneal myofibroblasts at metastatic foci promote dissemination of pancreatic cancer. International Journal of Oncology, 45(1), 113\u2013120. https:\/\/doi.org\/10.3892\/ijo.2014.2391","journal-title":"International Journal of Oncology"},{"issue":"9","key":"10295_CR43","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1590\/1414-431x20132907","volume":"46","author":"SQ Ji","year":"2013","unstructured":"Ji, S. Q., Cao, J., Zhang, Q. Y., Li, Y. Y., Yan, Y. Q., & Yu, F. X. (2013). Adipose tissue-derived stem cells promote pancreatic cancer cell proliferation and invasion. Brazilian Journal of Medical and Biological Research, 46(9), 758\u2013764. https:\/\/doi.org\/10.1590\/1414-431x20132907","journal-title":"Brazilian Journal of Medical and Biological Research"},{"issue":"12","key":"10295_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081859","volume":"8","author":"A Nowicka","year":"2013","unstructured":"Nowicka, A., Marini, F. C., Solley, T. N., Elizondo, P. B., Zhang, Y., Sharp, H. J., Broaddus, R., Kolonin, M., Mok, S. C., Thompson, M. S., Woodward, W. A., Lu, K., Salimian, B., Nagrath, D., & Klopp, A. H. (2013). Human omental-derived adipose stem cells increase ovarian cancer proliferation, migration, and chemoresistance. PLoS One, 8(12), Article e81859. https:\/\/doi.org\/10.1371\/journal.pone.0081859","journal-title":"PLoS One"},{"issue":"4","key":"10295_CR45","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nm.2344","volume":"17","author":"EA Collisson","year":"2011","unstructured":"Collisson, E. A., Sadanandam, A., Olson, P., Gibb, W. J., Truitt, M., Gu, S., Cooc, J., Weinkle, J., Kim, G. E., Jakkula, L., Feiler, H. S., Ko, A. H., Olshen, A. B., Danenberg, K. L., Tempero, M. A., Spellman, P. T., Hanahan, D., & Gray, J. W. (2011). Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nature Medicine, 17(4), 500\u2013503. https:\/\/doi.org\/10.1038\/nm.2344","journal-title":"Nature Medicine"},{"issue":"10","key":"10295_CR46","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/ng.3398","volume":"47","author":"RA Moffitt","year":"2015","unstructured":"Moffitt, R. A., Marayati, R., Flate, E. L., Volmar, K. E., Loeza, S. G., Hoadley, K. A., Rashid, N. U., Williams, L. A., Eaton, S. C., Chung, A. H., Smyla, J. K., Anderson, J. M., Kim, H. J., Bentrem, D. J., Talamonti, M. S., Iacobuzio-Donahue, C. A., Hollingsworth, M. A., & Yeh, J. J. (2015). Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nature Genetics, 47(10), 1168\u20131178. https:\/\/doi.org\/10.1038\/ng.3398","journal-title":"Nature Genetics"},{"issue":"7592","key":"10295_CR47","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature16965","volume":"531","author":"P Bailey","year":"2016","unstructured":"Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A. M., Gingras, M. C., Miller, D. K., Christ, A. N., Bruxner, T. J., Quinn, M. C., Nourse, C., Murtaugh, L. C., Harliwong, I., Idrisoglu, S., Manning, S., Nourbakhsh, E., Wani, S., Fink, L., Holmes, O., \u2026 Grimmond, S. M. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47\u201352. https:\/\/doi.org\/10.1038\/nature16965","journal-title":"Nature"},{"key":"10295_CR48","doi-asserted-by":"publisher","unstructured":"Chan-Seng-Yue, M., Kim, J. C., Wilson, G. W., Ng, K., Figueroa, E. F., O'Kane, G. M., Connor, A. A., Denroche, R. E., Grant, R. C., McLeod, J., Wilson, J. M., Jang, G. H., Zhang, A., Dodd, A., Liang, S. B., Borgida, A., Chadwick, D., Kalimuthu, S., Lungu, I.,\u2026Notta, F. (2020). Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution. Nat Genet, 52(2), 231\u2013240. https:\/\/doi.org\/10.1038\/s41588-019-0566-9","DOI":"10.1038\/s41588-019-0566-9"},{"issue":"8","key":"10295_CR49","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s41588-022-01134-8","volume":"54","author":"WL Hwang","year":"2022","unstructured":"Hwang, W. L., Jagadeesh, K. A., Guo, J. A., Hoffman, H. I., Yadollahpour, P., Reeves, J. W., Mohan, R., Drokhlyansky, E., Van Wittenberghe, N., Ashenberg, O., Farhi, S. L., Schapiro, D., Divakar, P., Miller, E., Zollinger, D. R., Eng, G., Schenkel, J. M., Su, J., Shiau, C., & Regev, A. (2022). Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment. Nature Genetics, 54(8), 1178\u20131191. https:\/\/doi.org\/10.1038\/s41588-022-01134-8","journal-title":"Nature Genetics"},{"key":"10295_CR50","doi-asserted-by":"publisher","unstructured":"Connor, A. A., Denroche, R. E., Jang, G. H., Lemire, M., Zhang, A., Chan-Seng-Yue, M., Wilson, G., Grant, R. C., Merico, D., Lungu, I., Bartlett, J. M. S., Chadwick, D., Liang, S. B., Eagles, J., Mbabaali, F., Miller, J. K., Krzyzanowski, P., Armstrong, H., Luo, X.,\u2026Gallinger, S. (2019). Integration of genomic and transcriptional features in pancreatic cancer reveals increased cell cycle progression in metastases. Cancer Cell, 35(2), 267\u2013282 e267. https:\/\/doi.org\/10.1016\/j.ccell.2018.12.010","DOI":"10.1016\/j.ccell.2018.12.010"},{"issue":"7837","key":"10295_CR51","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41586-020-2969-2","volume":"588","author":"X Jin","year":"2020","unstructured":"Jin, X., Demere, Z., Nair, K., Ali, A., Ferraro, G. B., Natoli, T., Deik, A., Petronio, L., Tang, A. A., Zhu, C., Wang, L., Rosenberg, D., Mangena, V., Roth, J., Chung, K., Jain, R. K., Clish, C. B., Vander Heiden, M. G., & Golub, T. R. (2020). A metastasis map of human cancer cell lines. Nature, 588(7837), 331\u2013336. https:\/\/doi.org\/10.1038\/s41586-020-2969-2","journal-title":"Nature"},{"key":"10295_CR52","doi-asserted-by":"publisher","unstructured":"O'Kane, G. M., Gr\u00fcnwald, B. T., Jang, G. H., Masoomian, M., Picardo, S., Grant, R. C., Denroche, R. E., Zhang, A., Wang, Y., Lam, B., Krzyzanowski, P. M., Lungu, I. M., Bartlett, J. M. S., Peralta, M., Vyas, F., Khokha, R., Biagi, J., Chadwick, D., Ramotar, S.,\u2026Fischer, S. E. (2020). GATA6 expression distinguishes classical and basal-like subtypes in advanced pancreatic cancer. Clinical Cancer Research, 26(18), 4901\u20134910. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-19-3724","DOI":"10.1158\/1078-0432.Ccr-19-3724"},{"issue":"8074","key":"10295_CR53","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/s41586-025-09017-8","volume":"643","author":"G Rademaker","year":"2025","unstructured":"Rademaker, G., Hernandez, G. A., Seo, Y., Dahal, S., Miller-Phillips, L., Li, A. L., Peng, X. L., Luan, C., Qiu, L., Liegeois, M. A., Wang, B., Wen, K. W., Kim, G. E., Collisson, E. A., Kruger, S. F., Boeck, S., Ormanns, S., Guenther, M., Heinemann, V., & Perera, R. M. (2025). PCSK9 drives sterol-dependent metastatic organ choice in pancreatic cancer. Nature, 643(8074), 1381\u20131390. https:\/\/doi.org\/10.1038\/s41586-025-09017-8","journal-title":"Nature"},{"issue":"1","key":"10295_CR54","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.canlet.2009.03.030","volume":"283","author":"WD Shi","year":"2009","unstructured":"Shi, W. D., Meng, Z. Q., Chen, Z., Lin, J. H., Zhou, Z. H., & Liu, L. M. (2009). Identification of liver metastasis-related genes in a novel human pancreatic carcinoma cell model by microarray analysis. Cancer Letters, 283(1), 84\u201391. https:\/\/doi.org\/10.1016\/j.canlet.2009.03.030","journal-title":"Cancer Letters"},{"key":"10295_CR55","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-23-1323","author":"N Yamaguchi","year":"2024","unstructured":"Yamaguchi, N., Wu, Y. G., Ravetch, E., Takahashi, M., Khan, A. G., Hayashi, A., Mei, W., Hsu, D., Umeda, S., de Stanchina, E., Lorenz, I. C., Iacobuzio-Donahue, C. A., & Tavazoie, S. F. (2024). A targetable secreted neural protein drives pancreatic cancer metastatic colonization and HIF1a nuclear retention. Cancer Discovery. https:\/\/doi.org\/10.1158\/2159-8290.Cd-23-1323","journal-title":"Cancer Discovery"},{"issue":"1","key":"10295_CR56","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s43018-024-00881-3","volume":"6","author":"JM Link","year":"2025","unstructured":"Link, J. M., Eng, J. R., Pelz, C., MacPherson-Hawthorne, K., Worth, P. J., Sivagnanam, S., Keith, D. J., Owen, S., Langer, E. M., Grossblatt-Wait, A., Salgado-Garza, G., Creason, A. L., Protzek, S., Egger, J., Holly, H., Heskett, M. B., Chin, K., Kirchberger, N., Betre, K., \u2026 Sears, R. C. (2025). Ongoing replication stress tolerance and clonal T cell responses distinguish liver and lung recurrence and outcomes in pancreatic cancer. Nature Cancer, 6(1), 123\u2013144. https:\/\/doi.org\/10.1038\/s43018-024-00881-3","journal-title":"Nature Cancer"},{"issue":"4","key":"10295_CR57","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s10555-020-09924-4","volume":"39","author":"LR Avula","year":"2020","unstructured":"Avula, L. R., Hagerty, B., & Alewine, C. (2020). Molecular mediators of peritoneal metastasis in pancreatic cancer. Cancer and Metastasis Reviews, 39(4), 1223\u20131243. https:\/\/doi.org\/10.1007\/s10555-020-09924-4","journal-title":"Cancer and Metastasis Reviews"},{"issue":"4","key":"10295_CR58","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/00006676-200105000-00003","volume":"22","author":"H Nishimori","year":"2001","unstructured":"Nishimori, H., Yasoshima, T., Denno, R., Shishido, T., Hata, F., Honma, T., Ura, H., Yamaguchi, K., Yagihashi, A., Tanaka, H., Kawaguchi, S., Kamiguchi, K., Isomura, H., Sato, N., & Hirata, K. (2001). A new peritoneal dissemination model established from the human pancreatic cancer cell line. Pancreas, 22(4), 348\u2013356.","journal-title":"Pancreas"},{"issue":"1","key":"10295_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38064-w","volume":"14","author":"L Wiedmann","year":"2023","unstructured":"Wiedmann, L., De Angelis Rigotti, F., Vaquero-Siguero, N., Donato, E., Espinet, E., Moll, I., Alsina-Sanchis, E., Bohnenberger, H., Fernandez-Florido, E., Mulfarth, R., Vacca, M., Gerwing, J., Conradi, L. C., Strobel, P., Trumpp, A., Mogler, C., Fischer, A., & Rodriguez-Vita, J. (2023). HAPLN1 potentiates peritoneal metastasis in pancreatic cancer. Nature Communications, 14(1), Article 2353. https:\/\/doi.org\/10.1038\/s41467-023-38064-w","journal-title":"Nature Communications"},{"issue":"2","key":"10295_CR60","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1158\/1541-7786.Mcr-19-0688","volume":"18","author":"LR Avula","year":"2020","unstructured":"Avula, L. R., Rudloff, M., El-Behaedi, S., Arons, D., Albalawy, R., Chen, X., Zhang, X., & Alewine, C. (2020). Mesothelin enhances tumor vascularity in newly forming pancreatic peritoneal metastases. Molecular Cancer Research, 18(2), 229\u2013239. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-19-0688","journal-title":"Molecular Cancer Research"},{"issue":"11","key":"10295_CR61","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.tranon.2019.07.009","volume":"12","author":"E Buscail","year":"2019","unstructured":"Buscail, E., Chauvet, A., Quincy, P., Degrandi, O., Buscail, C., Lamrissi, I., Moranvillier, I., Caumont, C., Verdon, S., Brisson, A., Marty, M., Chiche, L., Laurent, C., Vendrely, V., Moreau-Gaudry, F., Bedel, A., & Dabernat, S. (2019). CD63-GPC1-positive exosomes coupled with CA19-9 offer good diagnostic potential for resectable pancreatic ductal adenocarcinoma. Translational Oncology, 12(11), 1395\u20131403. https:\/\/doi.org\/10.1016\/j.tranon.2019.07.009","journal-title":"Translational Oncology"},{"issue":"3","key":"10295_CR62","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1053\/j.gastro.2020.05.052","volume":"159","author":"M Armacki","year":"2020","unstructured":"Armacki, M., Polaschek, S., Waldenmaier, M., Morawe, M., Ruhland, C., Schmid, R., Lechel, A., Tharehalli, U., Steup, C., Bektas, Y., Li, H., Kraus, J. M., Kestler, H. A., Kruger, S., Ormanns, S., Walther, P., Eiseler, T., & Seufferlein, T. (2020). Protein Kinase D1, Reduced in human pancreatic tumors, increases secretion of small extracellular vesicles from cancer cells that promote metastasis to lung in mice. Gastroenterology, 159(3), 1019-1035.e1022. https:\/\/doi.org\/10.1053\/j.gastro.2020.05.052","journal-title":"Gastroenterology"},{"issue":"1","key":"10295_CR63","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.canlet.2015.11.048","volume":"381","author":"DM Fink","year":"2016","unstructured":"Fink, D. M., Steele, M. M., & Hollingsworth, M. A. (2016). The lymphatic system and pancreatic cancer. Cancer Letters, 381(1), 217\u2013236. https:\/\/doi.org\/10.1016\/j.canlet.2015.11.048","journal-title":"Cancer Letters"},{"issue":"4","key":"10295_CR64","doi-asserted-by":"publisher","first-page":"E371","DOI":"10.1002\/ijc.26502","volume":"131","author":"J Sperveslage","year":"2012","unstructured":"Sperveslage, J., Frank, S., Heneweer, C., Egberts, J., Schniewind, B., Buchholz, M., Bergmann, F., Giese, N., Munding, J., Hahn, S. A., Kalthoff, H., Kl\u00f6ppel, G., & Sipos, B. (2012). Lack of CCR7 expression is rate limiting for lymphatic spread of pancreatic ductal adenocarcinoma. International Journal of Cancer, 131(4), E371-381. https:\/\/doi.org\/10.1002\/ijc.26502","journal-title":"International Journal of Cancer"},{"issue":"7","key":"10295_CR65","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1002\/ijc.24163","volume":"124","author":"Y Cui","year":"2009","unstructured":"Cui, Y., Wu, J., Zong, M., Song, G., Jia, Q., Jiang, J., & Han, J. (2009). Proteomic profiling in pancreatic cancer with and without lymph node metastasis. International Journal of Cancer, 124(7), 1614\u20131621. https:\/\/doi.org\/10.1002\/ijc.24163","journal-title":"International Journal of Cancer"},{"issue":"5","key":"10295_CR66","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1172\/jci44751","volume":"121","author":"D Kerjaschki","year":"2011","unstructured":"Kerjaschki, D., Bago-Horvath, Z., Rudas, M., Sexl, V., Schneckenleithner, C., Wolbank, S., Bartel, G., Krieger, S., Kalt, R., Hantusch, B., Keller, T., Nagy-Bojarszky, K., Huttary, N., Raab, I., Lackner, K., Krautgasser, K., Schachner, H., Kaserer, K., Rezar, S., & Krupitza, G. (2011). Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse. Journal of Clinical Investigation, 121(5), 2000\u20132012. https:\/\/doi.org\/10.1172\/jci44751","journal-title":"Journal of Clinical Investigation"},{"issue":"14","key":"10295_CR67","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1101\/gad.237677.114","volume":"28","author":"W Zheng","year":"2014","unstructured":"Zheng, W., Nurmi, H., Appak, S., Sabine, A., Bovay, E., Korhonen, E. A., Orsenigo, F., Lohela, M., D\u2019Amico, G., Holopainen, T., Leow, C. C., Dejana, E., Petrova, T. V., Augustin, H. G., & Alitalo, K. (2014). Angiopoietin 2 regulates the transformation and integrity of lymphatic endothelial cell junctions. Genes & Development, 28(14), 1592\u20131603. https:\/\/doi.org\/10.1101\/gad.237677.114","journal-title":"Genes & Development"},{"issue":"1","key":"10295_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02069-w","volume":"23","author":"S Kiri","year":"2024","unstructured":"Kiri, S., & Ryba, T. (2024). Cancer, metastasis, and the epigenome. Molecular Cancer, 23(1), Article 154. https:\/\/doi.org\/10.1186\/s12943-024-02069-w","journal-title":"Molecular Cancer"},{"key":"10295_CR69","doi-asserted-by":"publisher","unstructured":"Carstens, J. L., Yang, S., Correa de Sampaio, P., Zheng, X., Barua, S., McAndrews, K. M., Rao, A., Burks, J. K., Rhim, A. D., & Kalluri, R. (2021). Stabilized epithelial phenotype of cancer cells in primary tumors leads to increased colonization of liver metastasis in pancreatic cancer. Cell Reports, 35(2). https:\/\/doi.org\/10.1016\/j.celrep.2021.108990","DOI":"10.1016\/j.celrep.2021.108990"},{"key":"10295_CR70","doi-asserted-by":"publisher","unstructured":"Reichert, M., Bakir, B., Moreira, L., Pitarresi, J. R., Feldmann, K., Simon, L., Suzuki, K., Maddipati, R., Rhim, A. D., Schlitter, A. M., Kriegsmann, M., Weichert, W., Wirth, M., Schuck, K., Schneider, G., Saur, D., Reynolds, A. B., Klein-Szanto, A. J., Pehlivanoglu, B.,\u2026Rustgi, A. K. (2018). Regulation of epithelial plasticity determines metastatic organotropism in pancreatic cancer. Developmental Cell, 45(6), 696\u2013711.e698. https:\/\/doi.org\/10.1016\/j.devcel.2018.05.025","DOI":"10.1016\/j.devcel.2018.05.025"},{"issue":"4","key":"10295_CR71","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s10555-023-10132-z","volume":"42","author":"L Krauss","year":"2023","unstructured":"Krauss, L., Schneider, C., Hessmann, E., Saur, D., & Schneider, G. (2023). Epigenetic control of pancreatic cancer metastasis. Cancer and Metastasis Reviews, 42(4), 1113\u20131131. https:\/\/doi.org\/10.1007\/s10555-023-10132-z","journal-title":"Cancer and Metastasis Reviews"},{"issue":"1","key":"10295_CR72","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s13045-021-01203-1","volume":"14","author":"X Pan","year":"2021","unstructured":"Pan, X., Zhou, J., Xiao, Q., Fujiwara, K., Zhang, M., Mo, G., Gong, W., & Zheng, L. (2021). Cancer-associated fibroblast heterogeneity is associated with organ-specific metastasis in pancreatic ductal adenocarcinoma. Journal Of Hematology & Oncology, 14(1), 184. https:\/\/doi.org\/10.1186\/s13045-021-01203-1","journal-title":"Journal Of Hematology & Oncology"},{"issue":"19","key":"10295_CR73","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","volume":"364","author":"T Conroy","year":"2011","unstructured":"Conroy, T., Desseigne, F., Ychou, M., Bouch\u00e9, O., Guimbaud, R., B\u00e9couarn, Y., Adenis, A., Raoul, J. L., Gourgou-Bourgade, S., de la Fouchardi\u00e8re, C., Bennouna, J., Bachet, J. B., Khemissa-Akouz, F., P\u00e9r\u00e9-Verg\u00e9, D., Delbaldo, C., Assenat, E., Chauffert, B., Michel, P., Montoto-Grillot, C., & Ducreux, M. (2011). FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. The New England Journal of Medicine, 364(19), 1817\u20131825. https:\/\/doi.org\/10.1056\/NEJMoa1011923","journal-title":"The New England Journal of Medicine"},{"issue":"7","key":"10295_CR74","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/bjc.2016.45","volume":"114","author":"SM Stein","year":"2016","unstructured":"Stein, S. M., James, E. S., Deng, Y., Cong, X., Kortmansky, J. S., Li, J., Staugaard, C., Indukala, D., Boustani, A. M., Patel, V., Cha, C. H., Salem, R. R., Chang, B., Hochster, H. S., & Lacy, J. (2016). Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer. British Journal of Cancer, 114(7), 737\u2013743. https:\/\/doi.org\/10.1038\/bjc.2016.45","journal-title":"British Journal of Cancer"},{"issue":"18","key":"10295_CR75","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","volume":"369","author":"DD Von Hoff","year":"2013","unstructured":"Von Hoff, D. D., Ervin, T., Arena, F. P., Chiorean, E. G., Infante, J., Moore, M., Seay, T., Tjulandin, S. A., Ma, W. W., Saleh, M. N., Harris, M., Reni, M., Dowden, S., Laheru, D., Bahary, N., Ramanathan, R. K., Tabernero, J., Hidalgo, M., Goldstein, D., & Renschler, M. F. (2013). Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. New England Journal of Medicine, 369(18), 1691\u20131703. https:\/\/doi.org\/10.1056\/NEJMoa1304369","journal-title":"New England Journal of Medicine"},{"issue":"10409","key":"10295_CR76","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/s0140-6736(23)01366-1","volume":"402","author":"ZA Wainberg","year":"2023","unstructured":"Wainberg, Z. A., Melisi, D., Macarulla, T., Pazo Cid, R., Chandana, S. R., De La Fouchardi\u00e8re, C., Dean, A., Kiss, I., Lee, W. J., Goetze, T. O., Van Cutsem, E., Paulson, A. S., Bekaii-Saab, T., Pant, S., Hubner, R. A., Xiao, Z., Chen, H., Benzaghou, F., & O\u2019Reilly, E. M. (2023). NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): A randomised, open-label, phase 3 trial. The Lancet, 402(10409), 1272\u20131281. https:\/\/doi.org\/10.1016\/s0140-6736(23)01366-1","journal-title":"The Lancet"},{"issue":"2","key":"10295_CR77","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2300144","volume":"3","author":"A Carrato","year":"2024","unstructured":"Carrato, A., Pazo-Cid, R., Macarulla, T., Gallego, J., Jim\u00e9nez-Fonseca, P., Rivera, F., Cano, M. T., Rodriguez-Garrote, M., Pericay, C., Al\u00e9s, I., Layos, L., Gra\u00f1a, B., Iranzo, V., Gallego, I., Garcia-Carbonero, R., de Mena, I. R., Guill\u00e9n-Ponce, C., & Aranda, E. (2024). Nab-paclitaxel plus gemcitabine and FOLFOX in metastatic pancreatic cancer. NEJM Evidence, 3(2), Article EVIDoa2300144. https:\/\/doi.org\/10.1056\/EVIDoa2300144","journal-title":"NEJM Evidence"},{"issue":"10","key":"10295_CR78","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/s2468-1253(18)30196-1","volume":"3","author":"M Reni","year":"2018","unstructured":"Reni, M., Zanon, S., Peretti, U., Chiaravalli, M., Barone, D., Pircher, C., Balzano, G., Macchini, M., Romi, S., Gritti, E., Mazza, E., Nicoletti, R., Doglioni, C., Falconi, M., & Gianni, L. (2018). Nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in metastatic pancreatic adenocarcinoma (PACT-19): A randomised phase 2 trial. The Lancet Gastroenterology & Hepatology, 3(10), 691\u2013697. https:\/\/doi.org\/10.1016\/s2468-1253(18)30196-1","journal-title":"The Lancet Gastroenterology & Hepatology"},{"key":"10295_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00511-4","author":"L Mastrantoni","year":"2024","unstructured":"Mastrantoni, L., Chiaravalli, M., Spring, A., Beccia, V., Di Bello, A., Bagala, C., Bensi, M., Barone, D., Trovato, G., Caira, G., Giordano, G., Bria, E., Tortora, G., & Salvatore, L. (2024). Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic pancreatic cancer: A systematic review and Bayesian network meta-analysis. The Lancet Oncology. https:\/\/doi.org\/10.1016\/S1470-2045(24)00511-4","journal-title":"The Lancet Oncology"},{"issue":"23","key":"10295_CR80","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1200\/JCO.2013.53.6995","volume":"32","author":"H Oettle","year":"2014","unstructured":"Oettle, H., Riess, H., Stieler, J. M., Heil, G., Schwaner, I., Seraphin, J., G\u00f6rner, M., M\u00f6lle, M., Greten, T. F., Lakner, V., Bischoff, S., Sinn, M., D\u00f6rken, B., & Pelzer, U. (2014). Second-line oxaliplatin, folinic acid, and fluorouracil versus folinic acid and fluorouracil alone for gemcitabine-refractory pancreatic cancer: Outcomes from the CONKO-003 trial [Article]. Journal of Clinical Oncology, 32(23), 2423\u20132429. https:\/\/doi.org\/10.1200\/JCO.2013.53.6995","journal-title":"Journal of Clinical Oncology"},{"issue":"32","key":"10295_CR81","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.1200\/JCO.2016.68.5776","volume":"34","author":"S Gill","year":"2016","unstructured":"Gill, S., Ko, Y. J., Cripps, C., Beaudoin, A., Dhesy-Thind, S., Zulfiqar, M., Zalewski, P., Do, T., Cano, P., Lam, W. Y. H., Dowden, S., Grassin, H., Stewart, J., & Moore, M. (2016). PANCREOX: A randomized phase III study of fluorouracil\/leucovorin with or without oxaliplatin for second-line advanced pancreatic cancer in patients who have received gemcitabine-based chemotherapy [Article]. Journal of Clinical Oncology, 34(32), 3914\u20133920. https:\/\/doi.org\/10.1200\/JCO.2016.68.5776","journal-title":"Journal of Clinical Oncology"},{"issue":"10018","key":"10295_CR82","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0140-6736(15)00986-1","volume":"387","author":"A Wang-Gillam","year":"2016","unstructured":"Wang-Gillam, A., Li, C.-P., Bodoky, G., Dean, A., Shan, Y.-S., Jameson, G., Macarulla, T., Lee, K.-H., Cunningham, D., Blanc, J. F., Hubner, R. A., Chiu, C.-F., Schwartsmann, G., Siveke, J. T., Braiteh, F., Moyo, V., Belanger, B., Dhindsa, N., Bayever, E., \u2026 Wong, M. (2016). Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): A global, randomised, open-label, phase 3 trial. The Lancet, 387(10018), 545\u2013557. https:\/\/doi.org\/10.1016\/S0140-6736(15)00986-1","journal-title":"The Lancet"},{"key":"10295_CR83","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ejca.2018.12.007","volume":"108","author":"A Wang-Gillam","year":"2019","unstructured":"Wang-Gillam, A., Hubner, R. A., Siveke, J. T., Von Hoff, D. D., Belanger, B., de Jong, F. A., Mirakhur, B., & Chen, L.-T. (2019). NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors. European Journal of Cancer, 108, 78\u201387. https:\/\/doi.org\/10.1016\/j.ejca.2018.12.007","journal-title":"European Journal of Cancer"},{"issue":"7","key":"10295_CR84","doi-asserted-by":"publisher","first-page":"S1426","DOI":"10.1016\/j.annonc.2022.08.063","volume":"33","author":"L Wang","year":"2022","unstructured":"Wang, L., Qin, S., Zhou, Y., Zhang, S., Sun, X., Chen, Z., Cui, J., Zhao, P., Gu, K., Li, Z., Wang, J., Chen, X., Yao, J., Shen, L., Zhou, J., Wang, G., Bai, Y., Wang, Q., & Wang, H. (2022). HR070803 plus 5-FU\/LV versus placebo plus 5-FU\/LV in second-line therapy for gemcitabine-refractory locally advanced or metastatic pancreatic cancer: A multicentered, randomized, double-blind, parallel-controlled phase III trial (HR-IRI-APC). Annals of Oncology, 33(7), S1426\u2013S1426. https:\/\/doi.org\/10.1016\/j.annonc.2022.08.063","journal-title":"Annals of Oncology"},{"issue":"31","key":"10295_CR85","doi-asserted-by":"publisher","first-page":"4105","DOI":"10.1200\/JCO.2011.34.8904","volume":"29","author":"PJ Loehrer Sr","year":"2011","unstructured":"Loehrer, P. J., Sr., Feng, Y., Cardenes, H., Wagner, L., Brell, J. M., Cella, D., Flynn, P., Ramanathan, R. K., Crane, C. H., Alberts, S. R., & Benson, A. B., 3rd. (2011). Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: An Eastern Cooperative Oncology Group trial. Journal of Clinical Oncology, 29(31), 4105\u20134112. https:\/\/doi.org\/10.1200\/JCO.2011.34.8904","journal-title":"Journal of Clinical Oncology"},{"issue":"2, Supplement","key":"10295_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2024.07.1064","volume":"120","author":"M Peddi","year":"2024","unstructured":"Peddi, M., Engineer, R., Bhandare, M., Chaudhari, V., Krishnatry, R., Gudi, S., Ostwal, V., Ramaswamy, A., & Shrikhande, S. (2024). Matched pair analysis of locally advanced pancreatic cancer patients treated with neoadjuvant chemotherapy vs. neoadjuvant chemoradiotherapy (MAPLAP). International Journal of Radiation Oncology, Biology, Physics, 120(2, Supplement), Article e478\u2013e479.","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"17","key":"10295_CR87","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1001\/jama.2016.4324","volume":"315","author":"P Hammel","year":"2016","unstructured":"Hammel, P., Huguet, F., van Laethem, J. L., Goldstein, D., Glimelius, B., Artru, P., Borbath, I., Bouche, O., Shannon, J., Andre, T., Mineur, L., Chibaudel, B., Bonnetain, F., Louvet, C., Group, L. A. P. T. (2016). Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib: The LAP07 randomized clinical trial. JAMA, 315(17), 1844\u20131853. https:\/\/doi.org\/10.1001\/jama.2016.4324","journal-title":"JAMA"},{"key":"10295_CR88","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-24-01502","author":"R Fietkau","year":"2025","unstructured":"Fietkau, R., Ghadimi, M., Grutzmann, R., Wittel, U. A., Jacobasch, L., Uhl, W., Croner, R. S., Bechstein, W. O., Neumann, U. P., Waldschmidt, D., Boeck, S., Moosmann, N., Reinacher-Schick, A. C., Golcher, H., Adler, W., Semrau, S., Lubgan, D., Kallies, A., Hecht, M., Group, C. S. (2025). Benefit of chemoradiotherapy versus chemotherapy after induction therapy for conversion of unresectable into resectable pancreatic cancer: The randomized CONKO-007 trial. Journal of Clinical Oncology. https:\/\/doi.org\/10.1200\/JCO-24-01502","journal-title":"Journal of Clinical Oncology"},{"issue":"13","key":"10295_CR89","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1200\/JCO.2008.19.7921","volume":"27","author":"F Huguet","year":"2009","unstructured":"Huguet, F., Girard, N., Guerche, C. S., Hennequin, C., Mornex, F., & Azria, D. (2009). Chemoradiotherapy in the management of locally advanced pancreatic carcinoma: A qualitative systematic review. Journal of Clinical Oncology, 27(13), 2269\u20132277. https:\/\/doi.org\/10.1200\/JCO.2008.19.7921","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10295_CR90","doi-asserted-by":"publisher","first-page":"562","DOI":"10.4143\/crt.2017.105","volume":"50","author":"JS Chang","year":"2018","unstructured":"Chang, J. S., Chiu, Y. F., Yu, J. C., Chen, L. T., & Ch\u2019ang, H. J. (2018). The role of consolidation chemoradiotherapy in locally advanced pancreatic cancer receiving chemotherapy: An updated systematic review and meta-analysis. Cancer Research and Treatment, 50(2), 562\u2013574. https:\/\/doi.org\/10.4143\/crt.2017.105","journal-title":"Cancer Research and Treatment"},{"issue":"4","key":"10295_CR91","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.prro.2020.02.010","volume":"10","author":"AJ Koong","year":"2020","unstructured":"Koong, A. J., Toesca, D. A. S., Baclay, J. R. M., Pollom, E. L., von Eyben, R., Koong, A. C., & Chang, D. T. (2020). The utility of stereotactic ablative radiation therapy for palliation of metastatic pancreatic adenocarcinoma. Practical Radiation Oncology, 10(4), 274\u2013281. https:\/\/doi.org\/10.1016\/j.prro.2020.02.010","journal-title":"Practical Radiation Oncology"},{"issue":"32","key":"10295_CR92","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.1200\/JCO.24.00081","volume":"42","author":"EB Ludmir","year":"2024","unstructured":"Ludmir, E. B., Sherry, A. D., Fellman, B. M., Liu, S., Bathala, T., Haymaker, C., Medina-Rosales, M. N., Reuben, A., Holliday, E. B., Smith, G. L., Noticewala, S. S., Nicholas, S., Price, T. R., Martin-Paulpeter, R. M., Perles, L. A., Lee, S. S., Lee, M. S., Smaglo, B. G., Huey, R. W., \u2026 Tang, C. (2024). Addition of metastasis-directed therapy to systemic therapy for oligometastatic pancreatic ductal adenocarcinoma (EXTEND): A multicenter, randomized phase II trial. Journal of Clinical Oncology, 42(32), 3795\u20133805. https:\/\/doi.org\/10.1200\/JCO.24.00081","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"10295_CR93","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1056\/NEJMoa1903387","volume":"381","author":"T Golan","year":"2019","unstructured":"Golan, T., Hammel, P., Reni, M., Van Cutsem, E., Macarulla, T., Hall, M. J., Park, J. O., Hochhauser, D., Arnold, D., Oh, D. Y., Reinacher-Schick, A., Tortora, G., Algul, H., O\u2019Reilly, E. M., McGuinness, D., Cui, K. Y., Schlienger, K., Locker, G. Y., & Kindler, H. L. (2019). Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer. New England Journal of Medicine, 381(4), 317\u2013327. https:\/\/doi.org\/10.1056\/NEJMoa1903387","journal-title":"New England Journal of Medicine"},{"issue":"34","key":"10295_CR94","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.1200\/JCO.21.01604","volume":"40","author":"HL Kindler","year":"2022","unstructured":"Kindler, H. L., Hammel, P., Reni, M., Van Cutsem, E., Macarulla, T., Hall, M. J., Park, J. O., Hochhauser, D., Arnold, D., Oh, D. Y., Reinacher-Schick, A., Tortora, G., Algul, H., O\u2019Reilly, E. M., Bordia, S., McGuinness, D., Cui, K., Locker, G. Y., & Golan, T. (2022). Overall survival results from the POLO trial: A phase III study of active maintenance olaparib versus placebo for germline BRCA-mutated metastatic pancreatic cancer. Journal of Clinical Oncology, 40(34), 3929\u20133939. https:\/\/doi.org\/10.1200\/JCO.21.01604","journal-title":"Journal of Clinical Oncology"},{"issue":"13","key":"10295_CR95","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1200\/jco.19.01890","volume":"38","author":"T Golan","year":"2020","unstructured":"Golan, T., Kindler, H. L., Park, J. O., Reni, M., Macarulla, T., Hammel, P., Van Cutsem, E., Arnold, D., Hochhauser, D., McGuinness, D., Locker, G. Y., Goranova, T., Schatz, P., Liu, Y. Z., & Hall, M. J. (2020). Geographic and ethnic heterogeneity of germline BRCA1 or BRCA2 mutation prevalence among patients with metastatic pancreatic cancer screened for entry into the POLO trial. Journal of Clinical Oncology, 38(13), 1442\u20131454. https:\/\/doi.org\/10.1200\/jco.19.01890","journal-title":"Journal of Clinical Oncology"},{"issue":"30","key":"10295_CR96","doi-asserted-by":"publisher","first-page":"4714","DOI":"10.1200\/jco.22.02770","volume":"41","author":"MJ Moore","year":"2023","unstructured":"Moore, M. J., Goldstein, D., Hamm, J., Figer, A., Hecht, J. R., Gallinger, S., Au, H. J., Murawa, P., Walde, D., Wolff, R. A., Campos, D., Lim, R., Ding, K., Clark, G., Voskoglou-Nomikos, T., Ptasynski, M., & Parulekar, W. (2023). Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada Clinical Trials Group. Journal of Clinical Oncology, 41(30), 4714\u20134720. https:\/\/doi.org\/10.1200\/jco.22.02770","journal-title":"Journal of Clinical Oncology"},{"issue":"10","key":"10295_CR97","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1093\/annonc\/mdx343","volume":"28","author":"B Schultheis","year":"2017","unstructured":"Schultheis, B., Reuter, D., Ebert, M. P., Siveke, J., Kerkhoff, A., Berdel, W. E., Hofheinz, R., Behringer, D. M., Schmidt, W. E., Goker, E., De Dosso, S., Kneba, M., Yalcin, S., Overkamp, F., Schlegel, F., Dommach, M., Rohrberg, R., Steinmetz, T., Bulitta, M., & Strumberg, D. (2017). Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen in KRAS wildtype patients with locally advanced or metastatic pancreatic cancer: A multicenter, randomized phase IIb study. Annals Of Oncology, 28(10), 2429\u20132435. https:\/\/doi.org\/10.1093\/annonc\/mdx343","journal-title":"Annals Of Oncology"},{"issue":"33","key":"10295_CR98","doi-asserted-by":"publisher","first-page":"5163","DOI":"10.1200\/JCO.22.02630","volume":"41","author":"S Qin","year":"2023","unstructured":"Qin, S., Li, J., Bai, Y., Wang, Z., Chen, Z., Xu, R., Xu, J., Zhang, H., Chen, J., Yuan, Y., Liu, T., Yang, L., Zhong, H., Chen, D., Shen, L., Hao, C., Fu, D., Cheng, Y., Yang, J., \u2026 Zheng, Q. (2023). Nimotuzumab plus gemcitabine for K-Ras wild-type locally advanced or metastatic pancreatic cancer. Journal of Clinical Oncology, 41(33), 5163\u20135173. https:\/\/doi.org\/10.1200\/JCO.22.02630","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"10295_CR99","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/s1535-6108(02)00180-0","volume":"2","author":"C Tognon","year":"2002","unstructured":"Tognon, C., Knezevich, S. R., Huntsman, D., Roskelley, C. D., Melnyk, N., Mathers, J. A., Becker, L., Carneiro, F., MacPherson, N., Horsman, D., Poremba, C., & Sorensen, P. H. (2002). Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell, 2(5), 367\u2013376. https:\/\/doi.org\/10.1016\/s1535-6108(02)00180-0","journal-title":"Cancer Cell"},{"key":"10295_CR100","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5846","volume":"5","author":"N Stransky","year":"2014","unstructured":"Stransky, N., Cerami, E., Schalm, S., Kim, J. L., & Lengauer, C. (2014). The landscape of kinase fusions in cancer. Nature Communications, 5, Article 4846. https:\/\/doi.org\/10.1038\/ncomms5846","journal-title":"Nature Communications"},{"issue":"8","key":"10295_CR101","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1056\/NEJMoa1714448","volume":"378","author":"A Drilon","year":"2018","unstructured":"Drilon, A., Laetsch, T. W., Kummar, S., DuBois, S. G., Lassen, U. N., Demetri, G. D., Nathenson, M., Doebele, R. C., Farago, A. F., Pappo, A. S., Turpin, B., Dowlati, A., Brose, M. S., Mascarenhas, L., Federman, N., Berlin, J., El-Deiry, W. S., Baik, C., Deeken, J., \u2026 Hyman, D. M. (2018). Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children. New England Journal of Medicine, 378(8), 731\u2013739. https:\/\/doi.org\/10.1056\/NEJMoa1714448","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10295_CR102","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1097\/CJI.0b013e3181eec14c","volume":"33","author":"RE Royal","year":"2010","unstructured":"Royal, R. E., Levy, C., Turner, K., Mathur, A., Hughes, M., Kammula, U. S., Sherry, R. M., Topalian, S. L., Yang, J. C., Lowy, I., & Rosenberg, S. A. (2010). Phase 2 trial of single agent ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma. Journal Of Immunotherapy, 33(8), 828\u2013833. https:\/\/doi.org\/10.1097\/CJI.0b013e3181eec14c","journal-title":"Journal Of Immunotherapy"},{"issue":"10","key":"10295_CR103","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1001\/jamaoncol.2019.1588","volume":"5","author":"EM O\u2019Reilly","year":"2019","unstructured":"O\u2019Reilly, E. M., Oh, D. Y., Dhani, N., Renouf, D. J., Lee, M. A., Sun, W., Fisher, G., Hezel, A., Chang, S. C., Vlahovic, G., Takahashi, O., Yang, Y., Fitts, D., & Philip, P. A. (2019). Durvalumab with or without tremelimumab for patients with metastatic pancreatic ductal adenocarcinoma: A phase 2 randomized clinical trial. JAMA Oncology, 5(10), 1431\u20131438. https:\/\/doi.org\/10.1001\/jamaoncol.2019.1588","journal-title":"JAMA Oncology"},{"key":"10295_CR104","doi-asserted-by":"publisher","unstructured":"Kamath, S. D., Kalyan, A., Kircher, S., Nimeiri, H., Fought, A. J., Benson, A., 3rd., & Mulcahy, M. (2020). Ipilimumab and gemcitabine for advanced pancreatic cancer: A phase Ib study. The Oncologist, 25(5), Article e808. https:\/\/doi.org\/10.1634\/theoncologist.2019-0473","DOI":"10.1634\/theoncologist.2019-0473"},{"key":"10295_CR105","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-007883","author":"M Callahan","year":"2024","unstructured":"Callahan, M., Amin, A., Kaye, F. J., Morse, M. A., Taylor, M. H., Peltola, K. J., Sharma, P., O\u2019Reilly, E. M., Meadows Shropshire, S., O\u2019Brien, S., Tschaika, M., & Le, D. T. (2024). Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pancreatic adenocarcinoma (CheckMate 032). Journal for ImmunoTherapy of Cancer. https:\/\/doi.org\/10.1136\/jitc-2023-007883","journal-title":"Journal for ImmunoTherapy of Cancer"},{"issue":"10485","key":"10295_CR106","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S0140-6736(25)00261-2","volume":"405","author":"TF Stoop","year":"2025","unstructured":"Stoop, T. F., Javed, A. A., Oba, A., Koerkamp, B. G., Seufferlein, T., Wilmink, J. W., & Besselink, M. G. (2025). Pancreatic cancer. The Lancet, 405(10485), 1182\u20131202. https:\/\/doi.org\/10.1016\/S0140-6736(25)00261-2","journal-title":"The Lancet"},{"issue":"8","key":"10295_CR107","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/S1470-2045(22)00369-2","volume":"23","author":"KA Reiss","year":"2022","unstructured":"Reiss, K. A., Mick, R., Teitelbaum, U., O\u2019Hara, M., Schneider, C., Massa, R., Karasic, T., Tondon, R., Onyiah, C., Gosselin, M. K., Donze, A., Domchek, S. M., & Vonderheide, R. H. (2022). Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: A randomised, phase 1b\/2 trial. The Lancet Oncology, 23(8), 1009\u20131020. https:\/\/doi.org\/10.1016\/S1470-2045(22)00369-2","journal-title":"The Lancet Oncology"},{"issue":"27","key":"10295_CR108","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.1200\/jco.21.02511","volume":"40","author":"IM Chen","year":"2022","unstructured":"Chen, I. M., Johansen, J. S., Theile, S., Hjaltelin, J. X., Novitski, S. I., Brunak, S., Hasselby, J. P., Willemoe, G. L., Lorentzen, T., Madsen, K., Jensen, B. V., Wilken, E. E., Geertsen, P., Behrens, C., Nolsoe, C., Hermann, K. L., Svane, I. M., & Nielsen, D. (2022). Randomized phase II study of nivolumab with or without ipilimumab combined with stereotactic body radiotherapy for refractory metastatic pancreatic cancer (CheckPAC). Journal of Clinical Oncology, 40(27), 3180\u20133189. https:\/\/doi.org\/10.1200\/jco.21.02511","journal-title":"Journal of Clinical Oncology"},{"issue":"16_suppl","key":"10295_CR109","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1200\/JCO.2025.43.16_suppl.4161","volume":"43","author":"G-H Dai","year":"2025","unstructured":"Dai, G.-H., Jia, R., Si, H.-Y., Fan, M.-J., Zhang, N., Han, Q., Wang, Z.-K., Deng, G.-C., Liu, F.-F., Han, L., Gou, M., Tan, Z., Zhang, X., Shi, Y., Zhang, Y.-Y., & Jia, Y.-S. (2025). First-line treatment with surufatinib, camrelizumab, nab-paclitaxel, and S-1 in locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC): A phase Ib\/II randomized study. Journal of Clinical Oncology, 43(16_suppl), 4161\u20134161. https:\/\/doi.org\/10.1200\/JCO.2025.43.16_suppl.4161","journal-title":"Journal of Clinical Oncology"},{"issue":"12","key":"10295_CR110","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/s1470-2045(13)70447-9","volume":"14","author":"B Nordlinger","year":"2013","unstructured":"Nordlinger, B., Sorbye, H., Glimelius, B., Poston, G. J., Schlag, P. M., Rougier, P., Bechstein, W. O., Primrose, J. N., Walpole, E. T., Finch-Jones, M., Jaeck, D., Mirza, D., Parks, R. W., Mauer, M., Tanis, E., Van Cutsem, E., Scheithauer, W., & Gruenberger, T. (2013). Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): Long-term results of a randomised, controlled, phase 3 trial. The Lancet Oncology, 14(12), 1208\u20131215. https:\/\/doi.org\/10.1016\/s1470-2045(13)70447-9","journal-title":"The Lancet Oncology"},{"issue":"3","key":"10295_CR111","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/ags3.12655","volume":"7","author":"S Yasuda","year":"2023","unstructured":"Yasuda, S., Nagai, M., Terai, T., Kohara, Y., & Sho, M. (2023). Essential updates 2021\/2022: Surgical outcomes of oligometastasis in pancreatic ductal adenocarcinoma. Annals Of Gastroenterological Surgery, 7(3), 358\u2013366. https:\/\/doi.org\/10.1002\/ags3.12655","journal-title":"Annals Of Gastroenterological Surgery"},{"issue":"6","key":"10295_CR112","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.surg.2021.12.029","volume":"171","author":"A Hamad","year":"2022","unstructured":"Hamad, A., Underhill, J., Ansari, A., Thayaparan, V., Cloyd, J. M., Li, Y., Pawlik, T. M., Tsung, A., Abushahin, L., & Ejaz, A. (2022). Surgical treatment of hepatic oligometastatic pancreatic ductal adenocarcinoma: An analysis of the National Cancer Database. Surgery, 171(6), 1464\u20131470. https:\/\/doi.org\/10.1016\/j.surg.2021.12.029","journal-title":"Surgery"},{"issue":"5","key":"10295_CR113","doi-asserted-by":"publisher","first-page":"e1089","DOI":"10.1097\/sla.0000000000005481","volume":"277","author":"T Hank","year":"2023","unstructured":"Hank, T., Klaiber, U., Hinz, U., Sch\u00fctte, D., Leonhardt, C.-S., Bergmann, F., Hackert, T., J\u00e4ger, D., B\u00fcchler, M. W., & Strobel, O. (2023). Oncological outcome of conversion surgery after preoperative chemotherapy for metastatic pancreatic cancer. Annals Of Surgery, 277(5), e1089\u2013e1098. https:\/\/doi.org\/10.1097\/sla.0000000000005481","journal-title":"Annals Of Surgery"},{"issue":"12","key":"10295_CR114","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-033452","volume":"9","author":"M Wei","year":"2019","unstructured":"Wei, M., Shi, S., Hua, J., Xu, J., & Yu, X. (2019). Simultaneous resection of the primary tumour and liver metastases after conversion chemotherapy versus standard therapy in pancreatic cancer with liver oligometastasis: Protocol of a multicentre, prospective, randomised phase III control trial (CSPAC-1). BMJ Open, 9(12), Article e033452. https:\/\/doi.org\/10.1136\/bmjopen-2019-033452","journal-title":"BMJ Open"},{"issue":"16_suppl","key":"10295_CR115","doi-asserted-by":"publisher","first-page":"TPS4207","DOI":"10.1200\/JCO.2024.42.16_suppl.TPS4207","volume":"42","author":"P Jo","year":"2024","unstructured":"Jo, P., Ghadimi, M., Pelzer, U., Crede, M.-T.A., Telgmann, R., Seppanen, H., Bratlie, S. O., Besselink, M. G., Friede, T., & Siveke, J. T. (2024). Metapanc, intensified treatment in patients with oligometastatic pancreatic cancer: Multimodal surgical treatment versus systemic chemotherapy alone\u2014a prospective randomized controlled multicenter phase III trial. Journal of Clinical Oncology, 42(16_suppl), TPS4207\u2013TPS4207. https:\/\/doi.org\/10.1200\/JCO.2024.42.16_suppl.TPS4207","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"10295_CR116","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1007\/s00330-005-2652-x","volume":"15","author":"E Buscarini","year":"2005","unstructured":"Buscarini, E., Savoia, A., Brambilla, G., Menozzi, F., Reduzzi, L., Strobel, D., H\u00e4nsler, J., Buscarini, L., Gaiti, L., & Zambelli, A. (2005). Radiofrequency thermal ablation of liver tumors. European Radiology, 15(5), 884\u2013894. https:\/\/doi.org\/10.1007\/s00330-005-2652-x","journal-title":"European Radiology"},{"key":"10295_CR117","doi-asserted-by":"publisher","unstructured":"(2018) EASL clinical practice guidelines: Management of hepatocellular carcinoma. Journal of Hepatology, 69(1), 182\u2013236. https:\/\/doi.org\/10.1016\/j.jhep.2018.03.019","DOI":"10.1016\/j.jhep.2018.03.019"},{"issue":"3","key":"10295_CR118","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1148\/radiol.12111851","volume":"265","author":"L Solbiati","year":"2012","unstructured":"Solbiati, L., Ahmed, M., Cova, L., Ierace, T., Brioschi, M., & Goldberg, S. N. (2012). Small liver colorectal metastases treated with percutaneous radiofrequency ablation: Local response rate and long-term survival with up to 10-year follow-up. Radiology, 265(3), 958\u2013968. https:\/\/doi.org\/10.1148\/radiol.12111851","journal-title":"Radiology"},{"key":"10295_CR119","doi-asserted-by":"publisher","unstructured":"Ruers, T., Van Coevorden, F., Punt, C. J., Pierie, J. E., Borel-Rinkes, I., Ledermann, J. A., Poston, G., Bechstein, W., Lentz, M. A., Mauer, M., Folprecht, G., Van Cutsem, E., Ducreux, M., & Nordlinger, B. (2017). Local treatment of unresectable colorectal liver metastases: Results of a randomized phase II trial. Journal of the National Cancer Institute, 109(9). https:\/\/doi.org\/10.1093\/jnci\/djx015","DOI":"10.1093\/jnci\/djx015"},{"issue":"1","key":"10295_CR120","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/jhbp.1352","volume":"31","author":"WG Yun","year":"2024","unstructured":"Yun, W. G., Han, Y., Lee, M., Cho, Y. J., Jung, H. S., Kwon, W., & Jang, J. Y. (2024). Efficacy of local treatment for isolated liver metastasis after pancreatectomy in pancreatic ductal adenocarcinoma: A propensity score-matched analysis. Journal of Hepato-Biliary-Pancreatic Sciences, 31(1), 50\u201360. https:\/\/doi.org\/10.1002\/jhbp.1352","journal-title":"Journal of Hepato-Biliary-Pancreatic Sciences"},{"key":"10295_CR121","doi-asserted-by":"publisher","DOI":"10.1002\/jhbp.12051","author":"WG Yun","year":"2024","unstructured":"Yun, W. G., Han, Y., Jung, H. S., Kwon, W., Park, J. S., & Jang, J. Y. (2024). Emerging role of local treatment in the era of advanced systemic treatment in pancreatic cancer with liver metastasis: A systematic review and meta-analysis. Journal of Hepato-Biliary-Pancreatic Sciences. https:\/\/doi.org\/10.1002\/jhbp.12051","journal-title":"Journal of Hepato-Biliary-Pancreatic Sciences"},{"issue":"8","key":"10295_CR122","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","volume":"27","author":"E Van Cutsem","year":"2016","unstructured":"Van Cutsem, E., Cervantes, A., Adam, R., Sobrero, A., Van Krieken, J. H., Aderka, D., Aranda Aguilar, E., Bardelli, A., Benson, A., Bodoky, G., Ciardiello, F., D\u2019Hoore, A., Diaz-Rubio, E., Douillard, J. Y., Ducreux, M., Falcone, A., Grothey, A., Gruenberger, T., Haustermans, K., \u2026 Arnold, D. (2016). ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Annals Of Oncology, 27(8), 1386\u20131422. https:\/\/doi.org\/10.1093\/annonc\/mdw235","journal-title":"Annals Of Oncology"},{"key":"10295_CR123","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14051354","author":"T Yamamoto","year":"2022","unstructured":"Yamamoto, T., Satoi, S., Yamaki, S., Hashimoto, D., Ishida, M., Ikeura, T., Hirooka, S., Matsui, Y., Boku, S., Nakayama, S., Nakamaru, K., Shibata, N., Katsushima, U., & Sekimoto, M. (2022). Intraperitoneal paclitaxel treatment for patients with pancreatic ductal adenocarcinoma with peritoneal dissemination provides a survival benefit. Cancers. https:\/\/doi.org\/10.3390\/cancers14051354","journal-title":"Cancers"},{"issue":"1","key":"10295_CR124","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1056\/NEJMoa052985","volume":"354","author":"DK Armstrong","year":"2006","unstructured":"Armstrong, D. K., Bundy, B., Wenzel, L., Huang, H. Q., Baergen, R., Lele, S., Copeland, L. J., Walker, J. L., & Burger, R. A. (2006). Intraperitoneal cisplatin and paclitaxel in ovarian cancer. New England Journal of Medicine, 354(1), 34\u201343. https:\/\/doi.org\/10.1056\/NEJMoa052985","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10295_CR125","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/s1470-2045(04)01425-1","volume":"5","author":"O Glehen","year":"2004","unstructured":"Glehen, O., Mohamed, F., & Gilly, F. N. (2004). Peritoneal carcinomatosis from digestive tract cancer: New management by cytoreductive surgery and intraperitoneal chemohyperthermia. The Lancet Oncology, 5(4), 219\u2013228. https:\/\/doi.org\/10.1016\/s1470-2045(04)01425-1","journal-title":"The Lancet Oncology"},{"issue":"1","key":"10295_CR126","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00326-6","volume":"7","author":"D Cortes-Guiral","year":"2021","unstructured":"Cortes-Guiral, D., Hubner, M., Alyami, M., Bhatt, A., Ceelen, W., Glehen, O., Lordick, F., Ramsay, R., Sgarbura, O., Van Der Speeten, K., Turaga, K. K., & Chand, M. (2021). Primary and metastatic peritoneal surface malignancies. Nature Reviews Disease Primers, 7(1), Article 91. https:\/\/doi.org\/10.1038\/s41572-021-00326-6","journal-title":"Nature Reviews Disease Primers"},{"issue":"1","key":"10295_CR127","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1245\/s10434-022-12328-z","volume":"30","author":"TE Grotz","year":"2023","unstructured":"Grotz, T. E., Yonkus, J. A., Thiels, C. A., Warner, S. G., McWilliams, R. R., Mahipal, A., Bekaii-Saab, T. S., Cleary, S. P., Kendrick, M. L., & Truty, M. J. (2023). Cytoreduction with hyperthermic intraperitoneal chemoperfusion for pancreatic cancer with low-volume peritoneal metastasis: Results from a prospective pilot study. Annals of Surgical Oncology, 30(1), 395\u2013403. https:\/\/doi.org\/10.1245\/s10434-022-12328-z","journal-title":"Annals of Surgical Oncology"},{"issue":"12","key":"10295_CR128","doi-asserted-by":"publisher","first-page":"7833","DOI":"10.1245\/s10434-023-14138-3","volume":"30","author":"H Gudmundsdottir","year":"2023","unstructured":"Gudmundsdottir, H., Yonkus, J. A., Thiels, C. A., Warner, S. G., Cleary, S. P., Kendrick, M. L., Truty, M. J., & Grotz, T. E. (2023). Oncologic outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for highly selected patients with metastatic pancreatic ductal adenocarcinoma. Annals Of Surgical Oncology, 30(12), 7833\u20137839. https:\/\/doi.org\/10.1245\/s10434-023-14138-3","journal-title":"Annals Of Surgical Oncology"},{"key":"10295_CR129","doi-asserted-by":"publisher","first-page":"104151","DOI":"10.1016\/j.ebiom.2022.104151","volume":"82","author":"W Ceelen","year":"2022","unstructured":"Ceelen, W., Sandra, L., de Sande, L. V., Graversen, M., Mortensen, M. B., Vermeulen, A., Gasthuys, E., Reynders, D., Cosyns, S., Hoorens, A., & Willaert, W. (2022). Phase I study of intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for unresectable peritoneal metastases. eBioMedicine, 82, 104151. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104151","journal-title":"eBioMedicine"},{"issue":"9","key":"10295_CR130","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1016\/j.ejso.2022.05.030","volume":"48","author":"S Frassini","year":"2022","unstructured":"Frassini, S., Calabretto, F., Granieri, S., Fugazzola, P., Vigan\u00f2, J., Fazzini, N., Ansaloni, L., & Cobianchi, L. (2022). Intraperitoneal chemotherapy in the management of pancreatic adenocarcinoma: A systematic review and meta-analysis. European Journal of Surgical Oncology, 48(9), 1911\u20131921. https:\/\/doi.org\/10.1016\/j.ejso.2022.05.030","journal-title":"European Journal of Surgical Oncology"},{"issue":"9","key":"10295_CR131","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1007\/s11605-011-1605-8","volume":"15","author":"GJ Arnaoutakis","year":"2011","unstructured":"Arnaoutakis, G. J., Rangachari, D., Laheru, D. A., Iacobuzio-Donahue, C. A., Hruban, R. H., Herman, J. M., Edil, B. H., Pawlik, T. M., Schulick, R. D., Cameron, J. L., Meneshian, A., Yang, S. C., & Wolfgang, C. L. (2011). Pulmonary resection for isolated pancreatic adenocarcinoma metastasis: An analysis of outcomes and survival. Journal of Gastrointestinal Surgery, 15(9), 1611\u20131617. https:\/\/doi.org\/10.1007\/s11605-011-1605-8","journal-title":"Journal of Gastrointestinal Surgery"},{"issue":"1","key":"10295_CR132","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jtcvs.2016.02.066","volume":"152","author":"LA Robinson","year":"2016","unstructured":"Robinson, L. A., Tanvetyanon, T., Springett, G., Fontaine, J., Toloza, E., Hodul, P., Pimiento, J. M., & Malafa, M. (2016). Pulmonary metastasectomy for suspected pancreaticobiliary cancer. The Journal of Thoracic and Cardiovascular Surgery, 152(1), 75\u201382. https:\/\/doi.org\/10.1016\/j.jtcvs.2016.02.066","journal-title":"The Journal of Thoracic and Cardiovascular Surgery"},{"key":"10295_CR133","doi-asserted-by":"publisher","unstructured":"Scheffer, H. J., Vroomen, L. G., de Jong, M. C., Melenhorst, M. C., Zonderhuis, B. M., Daams, F., Vogel, J. A., Besselink, M. G., van Kuijk, C., Witvliet, J., de van der Schueren, M. A., de Gruijl, T. D., Stam, A. G., van den Tol, P. M., van Delft, F., Kazemier, G., & Meijerink, M. R. (2017). Ablation of locally advanced pancreatic cancer with percutaneous irreversible electroporation: Results of the phase I\/II PANFIRE study. Radiology, 282(2), 585\u2013597. https:\/\/doi.org\/10.1148\/radiol.2016152835","DOI":"10.1148\/radiol.2016152835"},{"issue":"1","key":"10295_CR134","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1148\/radiol.2019191109","volume":"294","author":"AH Ruarus","year":"2020","unstructured":"Ruarus, A. H., Vroomen, L., Geboers, B., van Veldhuisen, E., Puijk, R. S., Nieuwenhuizen, S., Besselink, M. G., Zonderhuis, B. M., Kazemier, G., de Gruijl, T. D., van Lienden, K. P., de Vries, J. J. J., Scheffer, H. J., & Meijerink, M. R. (2020). Percutaneous irreversible electroporation in locally advanced and recurrent pancreatic cancer (PANFIRE-2): A multicenter, prospective, single-arm, phase II study. Radiology, 294(1), 212\u2013220. https:\/\/doi.org\/10.1148\/radiol.2019191109","journal-title":"Radiology"},{"issue":"10","key":"10295_CR135","doi-asserted-by":"publisher","first-page":"6885","DOI":"10.1007\/s00330-024-10613-x","volume":"34","author":"JP Tasu","year":"2024","unstructured":"Tasu, J. P., Herpe, G., Damion, J., Richer, J. P., Debeane, B., Vionnet, M., Rouleau, L., Carretier, M., Ferru, A., Ingrand, P., & Tougeron, D. (2024). Irreversible electroporation to bring initially unresectable locally advanced pancreatic adenocarcinoma to surgery: The IRECAP phase II study. European Radiology, 34(10), 6885\u20136895. https:\/\/doi.org\/10.1007\/s00330-024-10613-x","journal-title":"European Radiology"},{"issue":"6","key":"10295_CR136","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1245\/s10434-019-07261-7","volume":"26","author":"D Moris","year":"2019","unstructured":"Moris, D., Machairas, N., Tsilimigras, D. I., Prodromidou, A., Ejaz, A., Weiss, M., Hasemaki, N., Felekouras, E., & Pawlik, T. M. (2019). Systematic review of surgical and percutaneous irreversible electroporation in the treatment of locally advanced pancreatic cancer. Annals Of Surgical Oncology, 26(6), 1657\u20131668. https:\/\/doi.org\/10.1245\/s10434-019-07261-7","journal-title":"Annals Of Surgical Oncology"},{"issue":"8_Supplement_2","key":"10295_CR137","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.Am2025-ct167","volume":"85","author":"D Wu","year":"2025","unstructured":"Wu, D., Liu, Y., Fu, L., Zhang, Y., Xu, L., Zhang, J., Li, H., & Hao, J. (2025). Abstract CT167: Phase II study of nimotuzumab combined with AG regimen in pancreatic cancer with liver metastases (PCLM): A prospective, single-arm trial. Cancer Research, 85(8_Supplement_2), Article CT167\u2013CT167. https:\/\/doi.org\/10.1158\/1538-7445.Am2025-ct167","journal-title":"Cancer Research"},{"key":"10295_CR138","doi-asserted-by":"publisher","unstructured":"Hajda, J., Leuchs, B., Angelova, A. L., Frehtman, V., Rommelaere, J., Mertens, M., Pilz, M., Kieser, M., Krebs, O., Dahm, M., Huber, B., Engeland, C. E., Mavratzas, A., Hohmann, N., Schreiber, J., J\u00e4ger, D., Halama, N., Sedlaczek, O., Gaida, M. M.,\u2026Ungerechts, G. (2021). Phase 2 trial of oncolytic H-1 parvovirus therapy shows safety and signs of immune system activation in patients with metastatic pancreatic ductal adenocarcinoma. Clinical Cancer Research, 27(20), 5546\u20135556. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-21-1020","DOI":"10.1158\/1078-0432.Ccr-21-1020"},{"issue":"8","key":"10295_CR139","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j.ejso.2019.03.039","volume":"45","author":"M Tanaka","year":"2019","unstructured":"Tanaka, M., Heckler, M., Mihaljevic, A. L., Sun, H., Klaiber, U., Heger, U., B\u00fcchler, M. W., & Hackert, T. (2019). CT response of primary tumor and CA19-9 predict resectability of metastasized pancreatic cancer after FOLFIRINOX. European Journal of Surgical Oncology, 45(8), 1453\u20131459. https:\/\/doi.org\/10.1016\/j.ejso.2019.03.039","journal-title":"European Journal of Surgical Oncology"},{"issue":"7793","key":"10295_CR140","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","volume":"578","author":"Consortium, I. T. P.-C. A. o. W. G.","year":"2020","unstructured":"Consortium, I. T. P.-C. A. o. W. G. (2020). Pan-cancer analysis of whole genomes. Nature, 578(7793), 82\u201393. https:\/\/doi.org\/10.1038\/s41586-020-1969-6","journal-title":"Nature"},{"key":"10295_CR141","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","volume":"82","author":"P Jacquet","year":"1996","unstructured":"Jacquet, P., & Sugarbaker, P. H. (1996). Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treatment and Research, 82, 359\u2013374. https:\/\/doi.org\/10.1007\/978-1-4613-1247-5_23","journal-title":"Cancer Treatment and Research"},{"issue":"2","key":"10295_CR142","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1245\/s10434-008-0234-2","volume":"16","author":"JL Koh","year":"2009","unstructured":"Koh, J. L., Yan, T. D., Glenn, D., & Morris, D. L. (2009). Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis. Annals Of Surgical Oncology, 16(2), 327\u2013333. https:\/\/doi.org\/10.1245\/s10434-008-0234-2","journal-title":"Annals Of Surgical Oncology"},{"key":"10295_CR143","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ygyno.2024.10.003","volume":"191","author":"P Pinto","year":"2024","unstructured":"Pinto, P., Moro, F., Alc\u00e1zar, J. L., Alessi, S., Avesani, G., Benesova, K., Burgetova, A., Calareso, G., Chiappa, V., Cibula, D., Fagotti, A., Franchi, D., Fr\u00fchauf, F., Jarkovsky, J., Kocian, R., Lambert, L., Masek, M., Panico, C., Pricolo, P., \u2026 Fischerov\u00e1, D. (2024). Prediction of non-resectability in tubo-ovarian cancer patients using peritoneal cancer index - A prospective multicentric study using imaging (ISAAC study). Gynecologic Oncology, 191, 132\u2013142. https:\/\/doi.org\/10.1016\/j.ygyno.2024.10.003","journal-title":"Gynecologic Oncology"},{"issue":"6","key":"10295_CR144","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1158\/2159-8290.Cd-19-1508","volume":"10","author":"H Sakamoto","year":"2020","unstructured":"Sakamoto, H., Attiyeh, M. A., Gerold, J. M., Makohon-Moore, A. P., Hayashi, A., Hong, J., Kappagantula, R., Zhang, L., Melchor, J. P., Reiter, J. G., Heyde, A., Bielski, C. M., Penson, A. V., G\u00f6nen, M., Chakravarty, D., O\u2019Reilly, E. M., Wood, L. D., Hruban, R. H., Nowak, M. A., \u2026 Iacobuzio-Donahue, C. A. (2020). The evolutionary origins of recurrent pancreatic cancer. Cancer Discovery, 10(6), 792\u2013805. https:\/\/doi.org\/10.1158\/2159-8290.Cd-19-1508","journal-title":"Cancer Discovery"},{"issue":"3","key":"10295_CR145","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/ng.3764","volume":"49","author":"AP Makohon-Moore","year":"2017","unstructured":"Makohon-Moore, A. P., Zhang, M., Reiter, J. G., Bozic, I., Allen, B., Kundu, D., Chatterjee, K., Wong, F., Jiao, Y., Kohutek, Z. A., Hong, J., Attiyeh, M., Javier, B., Wood, L. D., Hruban, R. H., Nowak, M. A., Papadopoulos, N., Kinzler, K. W., Vogelstein, B., & Iacobuzio-Donahue, C. A. (2017). Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer. Nature Genetics, 49(3), 358\u2013366. https:\/\/doi.org\/10.1038\/ng.3764","journal-title":"Nature Genetics"},{"issue":"11","key":"10295_CR146","doi-asserted-by":"publisher","DOI":"10.4161\/21624011.2014.962401","volume":"3","author":"ER Lutz","year":"2014","unstructured":"Lutz, E. R., Kinkead, H., Jaffee, E. M., & Zheng, L. (2014). Priming the pancreatic cancer tumor microenvironment for checkpoint-inhibitor immunotherapy. Oncoimmunology, 3(11), Article e962401. https:\/\/doi.org\/10.4161\/21624011.2014.962401","journal-title":"Oncoimmunology"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-025-10295-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-025-10295-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-025-10295-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:02:57Z","timestamp":1761087777000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10555-025-10295-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":146,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10295"],"URL":"https:\/\/doi.org\/10.1007\/s10555-025-10295-x","relation":{},"ISSN":["1573-7233"],"issn-type":[{"type":"electronic","value":"1573-7233"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"30 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors have consented to this submission.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}